Katherine B. Peters
Distinguished in Primitive Neuroectodermal Tumor (PNET)

Dr. Katherine B. Peters

Neurology
Duke Health
Duke Cancer Center
20 Duke Medicine Cir, 
Durham, NC 
On Staff At
Accepting New Patients
Offers Telehealth

Distinguished in Primitive Neuroectodermal Tumor (PNET)
Duke Health
Duke Cancer Center
20 Duke Medicine Cir, 
Durham, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

I am a neurologist and cancer doctor who treats brain tumors and researches ways to improve quality of life for brain tumor patients. As a college student, I thought I was going to be a scientist, but fell in love with studying the brain and its inner workings. I enjoy being at Duke, because I work with some of the top clinicians and researchers in the field, and a generous and warm-hearted staff that helps patients and their loved ones through treatment. It is hard to pick one thing I enjoy about my job. I enjoy seeing patients and their loved ones, being at the cutting edge of research and teaching the next generation of doctors. I think it is the chance to do so many different things that makes my job special. Outside of work, I enjoy shopping at farmer’s markets, cooking and exercising. I also collect Swatch watches - I have over 400!.

Dr. Peters is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Glioma, Gliomatosis Cerebri, Brain Tumor, and Astrocytoma.

Her clinical research consists of co-authoring 133 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Licenses
Psychiatry & Neurology in MD
Board Certifications
American Board Of Psychiatry/Neurology, Neurology
Fellowships
Cognitive Neurosciences, Johns Hopkins Medical Center (Maryland), Neuro-Oncology, Duke University School of Medicine
Hospital Affiliations
Duke Regional Hospital
Duke University Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Piedmont
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

Duke Cancer Center
20 Duke Medicine Cir, Durham, NC 27710
Call: 919-681-6900

Additional Areas of Focus

Dr. Peters has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Brain Tumor

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


9 Clinical Trials

A Multicenter Phase 2 Study of Oncolytic Polio/Rhinovirus Recombinant (Lerapolturev) in Recurrent WHO Grade IV Malignant Glioma Patients
A Multicenter Phase 2 Study of Oncolytic Polio/Rhinovirus Recombinant (Lerapolturev) in Recurrent WHO Grade IV Malignant Glioma Patients
Enrollment Status: Completed
Publish Date: July 11, 2025
Intervention Type: Biological, Drug
Study Drug: Oncolytic Polio/Rhinovirus Recombinant Vaccine
Study Phase: Phase 2
A Phase 2 Trial for Patients With Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide, and BMX-001
A Phase 2 Trial for Patients With Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide, and BMX-001
Enrollment Status: Completed
Publish Date: June 08, 2025
Intervention Type: Drug, Radiation
Study Drugs: BMX-001, Temozolomide
Study Phase: Phase 1/Phase 2
ATTAC-II: A Phase II Randomized, Blinded, and Placebo-controlled Trial of CMV RNA-Pulsed Dendritic Cells With Tetanus-Diphtheria Toxoid Vaccine in Patients With Newly-Diagnosed Glioblastoma
ATTAC-II: A Phase II Randomized, Blinded, and Placebo-controlled Trial of CMV RNA-Pulsed Dendritic Cells With Tetanus-Diphtheria Toxoid Vaccine in Patients With Newly-Diagnosed Glioblastoma
Enrollment Status: Completed
Publish Date: January 14, 2025
Intervention Type: Drug, Biological
Study Drugs: Cytomegalovirus-Associated RNA-Pulsed Dendritic Cell Vaccine, Tetanus/Diphtheria Toxoid, Granulocyte Colony-Stimulating Factor
Study Phase: Phase 2
Phase II Randomized Study to Evaluate Efficacy, Patient Satisfaction, and Compliance of the Oral Combination of Rolapitant (Varubi®) Plus Ondansetron vs. Ondansetron Monotherapy in Malignant Glioma Patients Receiving Radiotherapy (RT) and Concomitant Temozolomide
Phase II Randomized Study to Evaluate Efficacy, Patient Satisfaction, and Compliance of the Oral Combination of Rolapitant (Varubi®) Plus Ondansetron vs. Ondansetron Monotherapy in Malignant Glioma Patients Receiving Radiotherapy (RT) and Concomitant Temozolomide
Enrollment Status: Completed
Publish Date: July 11, 2023
Intervention Type: Drug
Study Drugs: Rolapitant, Ondansetron
Study Phase: Phase 2
ACTION: A Longitudinal Observational Study of Quality of Life, Functional Capacity and Physical Function in Glioblastoma Patients Treated With Tumor-Treating Fields
ACTION: A Longitudinal Observational Study of Quality of Life, Functional Capacity and Physical Function in Glioblastoma Patients Treated With Tumor-Treating Fields
Enrollment Status: Completed
Publish Date: June 09, 2021
Intervention Type: Device
Model of Early Palliative Care Intervention in Patients With Newly Diagnosed WHO Grade IV Malignant Glioma, a Single Arm Feasibility Study
Model of Early Palliative Care Intervention in Patients With Newly Diagnosed WHO Grade IV Malignant Glioma, a Single Arm Feasibility Study
Enrollment Status: Completed
Publish Date: November 24, 2020
Intervention Type: Behavioral
Study Phase: Not Applicable
Laser Interstitial Thermal Therapy (LITT) as Palliative Treatment for Patients With Malignant Glioma Requiring Standard Treatment Alternatives
Laser Interstitial Thermal Therapy (LITT) as Palliative Treatment for Patients With Malignant Glioma Requiring Standard Treatment Alternatives
Enrollment Status: Withdrawn
Publish Date: February 27, 2019
Intervention Type: Other
A Randomized Open Label Phase II Trial of Aprepitant (Emend) in Combination With Ondansetron Compared to Standard 5HT3 Serotonin Antagonist (Ondansetron) in the Prevention of Acute and Delayed Chemotherapy Induced Nausea and Vomiting (CINV) in Glioma Patients Receiving a Temozolomide Based Regimen
A Randomized Open Label Phase II Trial of Aprepitant (Emend) in Combination With Ondansetron Compared to Standard 5HT3 Serotonin Antagonist (Ondansetron) in the Prevention of Acute and Delayed Chemotherapy Induced Nausea and Vomiting (CINV) in Glioma Patients Receiving a Temozolomide Based Regimen
Enrollment Status: Completed
Publish Date: June 26, 2018
Intervention Type: Drug
Study Phase: Phase 2
Phase II Feasibility Study to Evaluate the Efficacy and Safety of Perampanel in Seizure Patients With Primary Glial Brain Tumors
Phase II Feasibility Study to Evaluate the Efficacy and Safety of Perampanel in Seizure Patients With Primary Glial Brain Tumors
Enrollment Status: Completed
Publish Date: April 27, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 8 Less Clinical Trials

133 Total Publications

Clinical trial of feasibility for mindfulness intervention for patients with newly diagnosed high grade glioma.
Clinical trial of feasibility for mindfulness intervention for patients with newly diagnosed high grade glioma.
Journal: Journal of neuro-oncology
Published: October 02, 2025
View All 133 Publications
Similar Doctors
Annick Desjardins
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Annick Desjardins
Neurology | Neurosurgery
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Annick Desjardins
Neurology | Neurosurgery

Duke Cancer Center Brain Tumor Clinic

20 Duke Medicine Cir, 
Durham, NC 
 (0.1 miles away)
919-684-5301
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients
Offers Telehealth

My primary focus is patient care and clinical research. My clinical research focuses on providing innovative and aggressive therapies to adults with primary brain tumors. I always keep the patient's quality of life foremost in my practice. I completed my residency in adult neurology at the University of Sherbrooke in Quebec. I finished a two-year fellowship in neuro-oncology at The Preston Robert Tisch Brain Tumor Center at Duke. Upon completion of my fellowship in 2005, I joined the Center as faculty. I am a fellow of the Royal College of Physicians of Canada. Dr. Desjardins is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Glioblastoma, Gliosarcoma, Embryonal Tumor with Multilayered Rosettes, and Atypical Teratoid Rhabdoid Tumor (ATRT).

Margaret O. Johnson
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Margaret O. Johnson
Neurology | Palliative Medicine
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Margaret O. Johnson
Neurology | Palliative Medicine

Duke Cancer Center

20 Duke Medicine Cir, 
Durham, NC 
 (0.1 miles away)
919-681-6900
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

I am an adult neurologist with further specialization in neuro-oncology. I treat adult patients with central nervous system (CNS) tumors of the brain and spine. My focus is combining compassionate patient-centered care with cutting-edge research. I want my patients to not only live longer, but also live better. I encourage my patients to be open and honest with me about their symptoms so I can find ways to help them feel better while undergoing treatment. What I love most about my job is seeing the courage and strength exhibited by my patients and their families. Dr. Johnson is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Brain Tumor, Astrocytoma, Glioma, and Glioblastoma.

Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Yasmeen Rauf
Neurology | Psychiatry
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Yasmeen Rauf
Neurology | Psychiatry

University Of North Carolina At Chapel Hill

101 Manning Dr, 
Chapel Hill, NC 
 (9.5 miles away)
984-974-1000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Yasmeen Rauf is a Neurologist and a Psychiatrist in Chapel Hill, North Carolina. Dr. Rauf is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Brain Tumor, Glioma, Astrocytoma, and Glioblastoma.

VIEW MORE PRIMITIVE NEUROECTODERMAL TUMOR (PNET) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Peters's expertise for a condition
ConditionClose
  • Elite
  • Astrocytoma
    Dr. Peters is
    Elite
    . Learn about Astrocytoma.
    See more Astrocytoma experts
  • Brain Tumor
    Dr. Peters is
    Elite
    . Learn about Brain Tumor.
    See more Brain Tumor experts
  • Glioblastoma
    Dr. Peters is
    Elite
    . Learn about Glioblastoma.
    See more Glioblastoma experts
  • Glioma
    Dr. Peters is
    Elite
    . Learn about Glioma.
    See more Glioma experts
  • Gliomatosis Cerebri
    Dr. Peters is
    Elite
    . Learn about Gliomatosis Cerebri.
    See more Gliomatosis Cerebri experts
  • Oligodendroglioma
    Dr. Peters is
    Elite
    . Learn about Oligodendroglioma.
    See more Oligodendroglioma experts
  • Distinguished
  • Atypical Teratoid Rhabdoid Tumor (ATRT)
    Dr. Peters is
    Distinguished
    . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
    See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
  • Embryonal Tumor with Multilayered Rosettes
    Dr. Peters is
    Distinguished
    . Learn about Embryonal Tumor with Multilayered Rosettes.
    See more Embryonal Tumor with Multilayered Rosettes experts
  • Ependymoma
    Dr. Peters is
    Distinguished
    . Learn about Ependymoma.
    See more Ependymoma experts
  • Gliosarcoma
    Dr. Peters is
    Distinguished
    . Learn about Gliosarcoma.
    See more Gliosarcoma experts
  • Meningioma
    Dr. Peters is
    Distinguished
    . Learn about Meningioma.
    See more Meningioma experts
  • Metastatic Brain Tumor
    Dr. Peters is
    Distinguished
    . Learn about Metastatic Brain Tumor.
    See more Metastatic Brain Tumor experts
View All 11 Distinguished Conditions
  • Advanced
  • Cerebral Ventricle Cancer
    Dr. Peters is
    Advanced
    . Learn about Cerebral Ventricle Cancer.
    See more Cerebral Ventricle Cancer experts
  • Choroid Plexus Papilloma
    Dr. Peters is
    Advanced
    . Learn about Choroid Plexus Papilloma.
    See more Choroid Plexus Papilloma experts
  • Medulloblastoma
    Dr. Peters is
    Advanced
    . Learn about Medulloblastoma.
    See more Medulloblastoma experts
  • Pineocytoma
    Dr. Peters is
    Advanced
    . Learn about Pineocytoma.
    See more Pineocytoma experts
  • Radiation Induced Meningioma
    Dr. Peters is
    Advanced
    . Learn about Radiation Induced Meningioma.
    See more Radiation Induced Meningioma experts
  • Seizures
    Dr. Peters is
    Advanced
    . Learn about Seizures.
    See more Seizures experts
  • Experienced
  • Absence Seizure
    Dr. Peters is
    Experienced
    . Learn about Absence Seizure.
    See more Absence Seizure experts
  • Acoustic Neuroma
    Dr. Peters is
    Experienced
    . Learn about Acoustic Neuroma.
    See more Acoustic Neuroma experts
  • Brain Stem Cancer
    Dr. Peters is
    Experienced
    . Learn about Brain Stem Cancer.
    See more Brain Stem Cancer experts
  • Diffuse Midline Glioma H3 K27M-Mutant
    Dr. Peters is
    Experienced
    . Learn about Diffuse Midline Glioma H3 K27M-Mutant.
    See more Diffuse Midline Glioma H3 K27M-Mutant experts
  • Dysembryoplastic Neuroepithelial Tumors (DNET)
    Dr. Peters is
    Experienced
    . Learn about Dysembryoplastic Neuroepithelial Tumors (DNET).
    See more Dysembryoplastic Neuroepithelial Tumors (DNET) experts
  • Epilepsy
    Dr. Peters is
    Experienced
    . Learn about Epilepsy.
    See more Epilepsy experts
View All 20 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment